A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility.
Justina Ucheojor OnwukaDapeng LiYupeng LiuHao HuangJing XuYing LiuYuanyuan ZhangYaShuang ZhaoPublished in: BMC cancer (2020)
Our study has identified a novel DNA methylation panel that is associated with CRC and could, if validated be useful for the prediction of CRC risk in the future.